National and Kapodistrian University of Athens
Κλινική αξιολόγηση και μελέτη ισομορφών της L-DOPA αποκαρβοξυλάσης και του νέου αποπτωτικού γονιδίου BCL2L12 στο γαστρικό καρκίνο
Abstract
dc:descriptionIn the present study, the expression analysis of both DDC and BCL2L12 mRNA isoforms has been accomplished, in gastric cancer. Stomach tissue specimens were obtained and the expression levels of DDC and BCL2L12 splice variants were assessed by a regular PCR methodology on a thermal cycler. A highly-sensitive, multiplex Real-Time PCR using TaqMan probes was also developed on a thermal cycler in order to achieve the quantification of the BCL2L12-A mRNA levels. Total protein was extracted from homogenized stomach tissues and the presence of the alt-DDC protein in stomach specimens was investigated by immunoblotting. The specificity of anti alt-DDC antibodies was evaluated using mass spectrometry. The chemotherapy response of the gastric cancer cell line AGS was analyzed with BCL2L12 and DDC gene expression being compared to the mRNA levels of other apoptosis-related genes. TaqMan Real-Time PCR analysis depicted an overexpression of BCL2L12-A in cancerous samples. Moreover, a statistically significant relationship was found between the expression of BCL2L12-A in stomach tissues and both the TNM stage of the disease and the grade of the tumor. Survival analysis has also depicted that BCL2L12-A negative patients have survived for a longer period than the BCL2L12-A positive ones. Regular PCR analysis for neuronal and non-neuronal DDC variants showed minor changes between healthy and cancer tissues. The expression of alt-DDC was detected in few stomach tissues and analysis depicted a non statistically significant up-regulation in cancer specimens. Western blotting analysis revealed the presence of the alt-DDC protein in gastric samples, though in varying levels. The chemosensitivity assay revealed that apoptotic genes and DDC appeared to behave in a diverse manner in the AGS cell line. The expression profiles of DDC and BCL2L12 in stomach cancer cells suggest their potential application in the discrimination and monitoring of the appropriate curative treatment, in the vein of a more drastic disease treatment.
Degree
thesis:*- Grantor dc:publisher
- National and Kapodistrian University of Athens
- Year dc:date
- 2009
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Κορμπάκης, Δημήτριος
- Korbakis, Dimitrios
Subjects
dc:subject × 20- Γαστρικός καρκίνος
- BCL2L12, Αποπτωτικό γονίδιο
- L-DOPA αποκαρβοξυλάση (DDC)
- Ποσοτική αλυσιδωτή αντίδραση πολυμεράσης σε πραγματικό χρόνο
- Καρκινική κυτταρική σειρά στομάχου
- Χημειοθεραπευτικά φάρμακα
- Μοριακοί βιοδείκτες καρκίνου
- Κλινική αξιολόγηση
- Gastric cancer
- Novel apoptotic gene BCL2L12
- L-dopa decarboxylase
- Quantitative real-time PCR
- Stomach cancer cell lines
- Chemotherapeutic drugs
- Molecular cancer biomarkers
- Clinical evaluation
- Natural Sciences
- Biological Sciences
- Φυσικές Επιστήμες
- Βιολογία
Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/27076